Archive for category: News


MINDDS WORKSHOP Neurodevelopmental Disorders and Copy Number Variants

January 30th 2020, Porto, Portugal. Prof. Natália Oliva-Teles, WG1 Leader On January 30th 2020 MINDDS WG1 organized a Workshop on the understanding of genomic f...

Read More

Happy 2020

The year is coming to an end, and we have made great progress for MINDDS during 2019. As a pan-European research community, we have worked worked across our Con...

Read More
2019_REPORT COST_Troina Meeting_1

14th Troina Meeting on Genetics of Neurodevelopmental Disorders

Meeting: 14th Troina Meeting on Genetics of Neurodevelopmental Disorders, April 4th-6th, 2019 Participant: Natália Oliva Teles – Management Committee Member (Su...

Read More
file-20190227-150688-e8d7t5 (1)

16p11.2: rare genetic changes linked to autism now connected to higher chance of other psychiatric disorders

In most of the trillion cells that make up our bodies, 23 pairs of chromosomes store the vital strands of DNA needed to make our bodies grow and function proper...

Read More

MINDDS Newsletter August 2018

The summer is here !, but we have still been busy with MINDDS through the last few months, building on our progress at the end of last year. To recap, we have ...

Read More

A Meeting of MINDDS

Mental Health is one of today’s great challenges. For the young generations, the Neurodevelopmental disorders (NDD) are some of the most common, but also the mo...

Read More

Academia Europaea – International networks: creating opportunities for collaborative research and funding

(from left to right): Prof Ole Petersen, Prof Sierd Cloetingh, Prof Adrian Harwood, Abdul Rahim, Prof Phil Jones and Sir John Skehel Professor Sierd Cloetingh, ...

Read More

A pan-European network for research into Neurodevelopmental Disorders

MINDDS will create a pan-European network of clinical scientists, preclinical researchers from both public and industrial sector and patient groups to advance s...

Read More


Understanding rare neurodevelopmental disorders (NDD) has the potential drive major new therapies for the common NDD of schizophrenia and Autism Spectrum Disorder (ASD).